Volume 88, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



is a new species of opportunistic, slow-growing, non-tuberculous closely related to that can currently be identified with the sequence of 16S rARN gene and the heat-shock protein 65. Few cases of patients infected by this have been reported and all of them were associated with human immunodeficiency virus or other immunosuppressive conditions. Clinical management is complex, because there is not a clear correlation between the antibiotic susceptibility testing and the patient's clinical outcome.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Selvarangan R, Wu WK, Nguyen TT, Carlson L, Wallis CK, Stiglich SK, Chen YC, Jost KC, Jr Prentice JL, Wallace RJ, Jr Barrett SL, Cookson BT, Coyle MB, , 2004. Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol 42: 5259.[Crossref] [Google Scholar]
  2. van Ingen J, Tortoli E, Selvarangan R, Coyle MB, Crump JA, Morrissey AB, Dekhuijzen PN, Boeree MJ, van Soolingen D, , 2011. Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species. Int J Syst Evol Microbiol 61: 12931298.[Crossref] [Google Scholar]
  3. Gamperli A, Bosshard PP, Sigrist T, Brandli O, Wildermuth S, Weber R, Mueller NJ, , 2005. Pulmonary Mycobacterium sherrisii infection in a human immunodeficiency virus type 1-infected patient. J Clin Microbiol 43: 42834285.[Crossref] [Google Scholar]
  4. Loulergue P, Lamontagne F, Vincent V, Rossier A, Pialoux G, , 2007. Mycobacterium sherrisii: a new opportunistic agent in HIV infection? AIDS 21: 893894.[Crossref] [Google Scholar]
  5. Tortoli E, Galli L, Andebirhan T, Baruzzo S, Chiappini E, de Martino M, Brown-Elliott BA, , 2007. The first case of Mycobacterium sherrisii disseminated infection in a child with AIDS. AIDS 21: 14961498.[Crossref] [Google Scholar]
  6. Tortoli E, Mariottin A, Mazzarelli G, , 2007. Mycobacterium sherrisii isolation from a patient with pulmonary disease. Diagn Microbiol Infect Dis 57: 221223.[Crossref] [Google Scholar]
  7. Barrera L, Palmero D, Paul R, Lopez B, Grupo de Investigacion de M. simiae; , 2010. Disease due to Mycobacterium simiae and “Mycobacterium sherrisii” in Argentina. Medicina (B Aires) 70: 343346. [Google Scholar]
  8. Ho J, Balm M, Huggan P, Chew N, Venkatachalam I, Archuleta S, , 2012. Immune reconstitution inflammatory syndrome associated with disseminated Mycobacterium sherrisii infection. Int J STD AIDS 23: 369370.[Crossref] [Google Scholar]
  9. Crump JA, van Ingen J, Morrissey AB, Boeree MJ, Mavura DR, Swai B, Thielman NM, Bartlett JA, Grossman H, Maro VP, van Soolingen D, , 2009. Invasive disease caused by nontuberculous mycobacteria, Tanzania. Emerg Infect Dis 15: 5355.[Crossref] [Google Scholar]
  10. Valero G, Moreno F, Graybill J, , 1994. Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in a murine model of disseminated infection. Antimicrob Agents Chemother 38: 26762677.[Crossref] [Google Scholar]
  11. van Ingen J, Totten SE, Helstrom NK, Heifets LB, Boeree MJ, Daley CL, , 2012. In vitro synergy between clofazimine and amikacin in nontuberculous mycobacterial disease. Antimicrob Agents Chemother 56: 53246327.[Crossref] [Google Scholar]
  12. van Ingen J, Totten SE, Heifets LB, Boeree MJ, Daley CL, , 2012. Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. Int J Antimicrob Agents 39: 173176.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 13 Sep 2012
  • Accepted : 11 Jan 2013
  • Published online : 01 May 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error